Psoriasis Unknown Status Phase 4 Trials for Adalimumab (DB00051)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01088165The Influence of Adalimumab on Cardiovascular and Metabolic Risk in PsoriasisPrevention